Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

Mean amyloid levels remained below 24.1 centiloids at 3 years for participants who completed donanemab treatment by 1 year.

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new study published in ...

Researchers have discovered a defect in how cells produce exosomes, a problem linked to a mutation found in patients with dementia. They may be incredibly small, but their impact on human health could ...

In multivariable adjusted model, no association seen for impaired kidney function with increased hazard of dementia compared with preserved kidney function.

Standing on a purple Walk to End Alzheimer’s stage in front of a crowd holding purple, yellow and orange pinwheel flowers ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

Alzheimer’s disease accounts for most of the cases of dementia, a condition characterized by progressive or persistent loss ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

New research published in the journal eNeuro examined whether eliminating a protein that is elevated in the brains of those ...